Search Within

David Hyman

  1. "Annals of Oncology"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (7)
  3. Editorial (1)
Groups
  1. Department of Medicine (22)
  2. Early Drug Development Service (22)
  3. Solid Tumor Oncology Division (22)
  4. Thoracic Oncology (11)
  5. GSK Faculty (8)
  6. Human Oncology and Pathogenesis Program (8)

More Groups

People
  1. Alexander Drilon (11)
  2. Alison Schram (5)
  3. David Solit (4)
  4. Marc Ladanyi (4)
  5. Michael Berger (4)
  6. Nikolaus Schultz (4)

More People

Years
  1. 2020 (2)
  2. 2019 (13)
  3. 2018 (1)
  4. 2017 (2)
  5. 2016 (3)
  6. 2014 (1)
Publications
  1. Annals of Oncology (22)
Publishers
  1. Oxford University Press (22)

Results (22)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I dose escalation of MSC-1, a humanized anti-LIF monoclonal antibody, in patients (pts) with advanced solid tumours: Updated results
    Meeting Abstract

    Borazanci, E.; Schram, A.; Brana, I.; Vieito Villar, M.; Garralda, E.; Spreafico, A.; Oliva, M.; Lakhani, N.; Wasserman, R.; Hoffman, K.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Update on the phase II SUMMIT trial: Neratinib + fulvestrant for HER2-mutant, HR-positive, metastatic breast cancer
    Meeting Abstract

    Smyth, L. M.; Saura, C.; Piha-Paul, S. A.; Lu, J.; Mayer, I. A.; Brufksy, A. M.; Spanggaard, I.; Arnedos, M.; Cutler, R. E.; Hyman, D. M.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Treating HER2-mutant advanced biliary tract cancer with neratinib: Benefits of HER2-directed targeted therapy in the phase 2 SUMMIT 'basket; trial
    Meeting Abstract

    Harding, J.; Cleary, J.; Shapiro, G.; Braña, I.; Moreno, V.; Quinn, D.; Borad, M.; Loi, S.; Spanggaard, I.; Stemmer, S.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Debio 1347 in patients with gastrointestinal cancers harboring an FGFR gene fusion: Preliminary results
    Meeting Abstract

    Matos, I.; Goyal, L.; Cleary, J.; Voss, M.; Oh, D.; Bernstam, F. M.; Ng, C.; Iyer, G.; Ishii, N.; Hu, Y.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Genomic alterations in breast cancer: Level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
    Journal Article

    Condorelli, R.; Mosele, F.; Verret, B.; Bachelot, T.; Bedard, P. L.; Cortes, J.; Hyman, D. M.; Juric, D.; Krop, I.; Bieche, I.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Comparing metastatic (M) young onset (YO) colorectal cancer (CRC) with average onset (AO): Do they differ clinically and genetically?
    Meeting Abstract

    Dos Santos Fernandes, G.; Chatila, W.; Yaeger, R.; Mendelsohn, R.; Stadler, Z.; Segal, N. H.; Varghese, A.; Reidy, D.; Diaz, L.; Shia, J.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Clinical and molecular characterization of patients with cancer of unknown primary in the modern era
    Journal Article

    Varghese, A. M.; Arora, A.; Capanu, M.; Camacho, N.; Won, H. H.; Zehir, A.; Gao, J.; Chakravarty, D.; Schultz, N.; Klimstra, D. S.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Oncologist use and perception of large panel next-generation tumor sequencing
    Journal Article

    Schram, A. M.; Reales, D.; Galle, J.; Cambria, R.; Durany, R.; Feldman, D.; Sherman, E.; Rosenberg, J.; D'Andrea, G.; Baxi, S.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • A phase II basket study of the oral TRK inhibitor LOXO-101 in adult subjects with NTRK fusion-positive tumors
    Meeting Abstract

    Drilon, A.; Hong, D.; Deeken, J.; Smith, S.; Reynolds, M.; Cruickshank, S.; Deegan, M.; Ku, N.; Hyman, D.
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Lurbinectedin (PM01183) plus paclitaxel (P), recommended dose (RD) expansion results with or without the addition of bevacizumab (Bev) in patients (pts) with selected solid tumors
    Meeting Abstract

    Drilon, A.; Garralda, E.; Stathis, A.; Szyldergemajn, S.; Hyman, D.; Boni, V.; Griguolo, G.; Martinez, E. J.; Makker, V.; Canziani, L.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save